Marialuisa Zedde Selected Research

Marialuisa Zedde Research Topics

11	Stroke (Strokes) 04/2022 - 01/2016
9	Ischemic Stroke 01/2022 - 11/2017
8	Hemorrhage 01/2022 - 11/2017
5	Atrial Fibrillation 01/2022 - 11/2017
3	COVID-19 01/2022 - 11/2021
3	Embolic Stroke 06/2021 - 01/2018
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2022 - 11/2021
2	Inflammation (Inflammations) 11/2021 - 06/2021
2	Hypertension (High Blood Pressure) 10/2021 - 01/2021
2	Siderosis 01/2019 - 01/2018
2	Leukoaraiosis 01/2019 - 01/2018
2	Cerebral Hemorrhage 01/2018 - 01/2018
1	Mucopolysaccharidosis II (Hunter Syndrome) 05/2022
1	Unconsciousness (Loss of Consciousness) 04/2022
1	Epilepsy (Aura) 04/2022
1	Seizures (Absence Seizure) 04/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 11/2021
1	Coronary Disease (Coronary Heart Disease) 06/2021
1	Moyamoya Disease (Moya-Moya Disease) 01/2021
1	Chorea (Rheumatic Chorea) 01/2021
1	Migraine Disorders (Migraine) 01/2021
1	Dementia (Dementias) 01/2019
1	Thrombosis (Thrombus) 06/2017
1	Embolism (Embolus) 06/2017
1	Fabry Disease (Fabry's Disease) 01/2016
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2016

8	AnticoagulantsIBA 01/2022 - 11/2017
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2019
2	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2020
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 01/2018
2	Vitamin K FDA Link 01/2020 - 11/2017
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2017
2	RivaroxabanIBA 01/2018 - 11/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2016
1	Pharmaceutical PreparationsIBA 04/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	ORALIT (ORS)IBA 10/2021
1	InterleukinsIBA 06/2021
1	Tubulin ModulatorsIBA 06/2021
1	Colchicine FDA LinkGeneric 06/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	SteroidsIBA 01/2021
1	IS 35IBA 01/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 01/2018
1	apixabanIBA 11/2017
1	Dabigatran FDA Link 11/2017
1	RNA (Ribonucleic Acid)IBA 06/2017
1	CholesterolIBA 01/2016
1	alpha-Galactosidase (Beano)IBA 01/2016

8	Therapeutics 04/2022 - 01/2018
5	Secondary Prevention 04/2022 - 11/2017
2	Thrombectomy 01/2020 - 03/2018
1	Surgical Decompression 05/2022
1	Extracorporeal Circulation 04/2022
1	Critical Care (Surgical Intensive Care) 01/2022
1	Immunotherapy 11/2021
1	Aftercare (After-Treatment) 11/2021
1	Thrombolytic Therapy 01/2020